AroCell AB (ST:AROC) — Stock Price
AroCell AB (ST:AROC) is currently trading at Skr0.54 SEK, up 0.00% today. Over the past 52 weeks, shares have ranged between Skr0.54 and Skr0.54. This page tracks AroCell AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see AroCell AB market capitalisation.
AroCell AB (AROC) Stock Price Chart — Daily History & Trading Volume
The chart below tracks AroCell AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.
Daily price history is not currently available for AroCell AB.
AroCell AB Income Statement — Revenue, Profit & Earnings by Year
AroCell AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | Skr57.44 Million | Skr43.04 Million | Skr36.99 Million | Skr12.00 Million | Skr84.00K |
| Cost of Revenue | Skr45.70 Million | Skr45.14 Million | Skr39.09 Million | Skr17.04 Million | Skr21.00K |
| Gross Profit | Skr11.73 Million | Skr-2.10 Million | Skr-2.10 Million | Skr-5.04 Million | Skr63.00K |
| Research & Development | Skr22.79 Million | Skr25.24 Million | Skr24.43 Million | Skr19.83 Million | Skr12.60 Million |
| SG&A | Skr14.27 Million | Skr15.81 Million | Skr19.46 Million | Skr10.61 Million | Skr5.25 Million |
| Total Operating Expenses | Skr55.16 Million | Skr57.68 Million | Skr58.02 Million | Skr45.77 Million | Skr24.11 Million |
| Operating Income | Skr-43.43 Million | Skr-59.78 Million | Skr-59.30 Million | Skr-50.57 Million | Skr-24.05 Million |
| EBITDA | Skr-33.53 Million | Skr-13.76 Million | Skr-12.94 Million | Skr-30.26 Million | Skr-19.46 Million |
| EBIT | Skr-43.43 Million | Skr-59.30 Million | Skr-60.12 Million | Skr-50.57 Million | Skr-24.05 Million |
| Interest Expense | Skr3.00K | Skr13.00K | Skr5.00K | Skr1.00K | Skr0.00 |
| Income Before Tax | Skr-42.45 Million | Skr-59.30 Million | Skr-59.30 Million | Skr-50.57 Million | Skr-24.05 Million |
| Income Tax Expense | — | Skr1.13 Million | Skr-326.00K | Skr-547.00K | Skr-4.59 Million |
| Net Income | Skr-42.45 Million | Skr-59.30 Million | Skr-58.97 Million | Skr-50.03 Million | Skr-19.46 Million |
AroCell AB Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes AroCell AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | Skr134.13 Million | Skr174.89 Million | Skr236.01 Million | Skr227.41 Million | Skr60.48 Million |
| Total Current Assets | Skr66.93 Million | Skr65.10 Million | Skr83.35 Million | Skr31.62 Million | Skr44.23 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | Skr12.33 Million | Skr6.08 Million | Skr7.12 Million | Skr2.72 Million | Skr25.00K |
| Inventory | Skr5.73 Million | Skr6.07 Million | Skr7.38 Million | Skr6.91 Million | Skr1.42 Million |
| Property, Plant & Equipment | — | — | Skr3.32 Million | Skr1.16 Million | Skr538.00K |
| Goodwill | Skr59.41 Million | Skr98.99 Million | Skr138.57 Million | Skr178.15 Million | Skr0.00 |
| Total Liabilities | Skr12.93 Million | Skr11.25 Million | Skr13.32 Million | Skr9.96 Million | Skr4.22 Million |
| Total Current Liabilities | Skr12.93 Million | Skr11.25 Million | Skr13.32 Million | Skr9.96 Million | Skr4.22 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | Skr-47.78 Million | Skr-50.72 Million | Skr-65.19 Million | Skr-18.40 Million | Skr-42.01 Million |
| Total Stockholder Equity | Skr121.20 Million | Skr163.65 Million | Skr222.69 Million | Skr213.52 Million | Skr56.26 Million |
| Retained Earnings | Skr-342.85 Million | Skr-300.40 Million | Skr-241.10 Million | Skr-174.67 Million | Skr-129.41 Million |
AroCell AB Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how AroCell AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | Skr-2.36 Million | Skr-13.44 Million | Skr-13.69 Million | Skr-28.21 Million | Skr-18.90 Million |
| Capital Expenditures | Skr581.00K | Skr498.00K | Skr4.06 Million | Skr370.00K | Skr53.00K |
| Free Cash Flow | Skr-2.36 Million | Skr-14.71 Million | Skr-17.75 Million | Skr-28.58 Million | Skr-18.95 Million |
| Investing Cash Flow | Skr-581.00K | Skr-1.28 Million | Skr-10.12 Million | Skr4.54 Million | Skr-53.00K |
| Financing Cash Flow | — | Skr250.00K | Skr70.60 Million | Skr70.60 Million | Skr47.34 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Skr43.17 Million | Skr45.54 Million | Skr47.18 Million | Skr4.79 Million | Skr4.59 Million |
| Change in Cash | Skr-2.94 Million | Skr-14.47 Million | Skr46.79 Million | Skr-23.66 Million | Skr28.38 Million |
AroCell AB Earnings History — EPS Actual vs. Analyst Estimates
Track AroCell AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 07, 2025 | -0.05 | — | — |
| Feb 19, 2025 | -0.04 | — | — |
| Oct 24, 2024 | -0.04 | — | — |
| Jun 30, 2024 | -0.06 | — | — |
| May 03, 2024 | -0.05 | — | — |
| Feb 22, 2024 | -0.07 | — | — |
| Nov 02, 2023 | -0.06 | — | — |
| Aug 23, 2023 | -0.07 | — | — |